Organon & Co | OGN - Action





Action Changement Date
Bristol-Myers Squibb USD 2.76B 21M 2025-09
Celltrion KRW 2.71T 121.94B 2025-06
Cspc Pharmaceutical CNY 2.87B 259.23M 2025-06
Divis Laboratories Ltd INR 32.36B 910M 2025-03
Gilead Sciences USD 1.78B 40M 2025-09
Glaxosmithkline GBP 6.12B 46M 2025-09
Kangmei Pharma CNY 2.45B 12.27M 2025-09
Knight Therapeutics CAD 95.4M 2.91M 2024-03
Laboratorios Farma EUR 327.67M 2.28M 2025-06
Medical Developments International AUD 9.45M 679K 2025-06
Merck USD 6.44B 157M 2025-09
Novartis USD 6.42B 114M 2025-09
Organigram Holdings CAD 132.71M 8.76M 2025-12
Organon & Co USD 1.49B 34M 2025-09
Pharma Mar EUR 50.64M 1.13M 2025-12
Qiagen NV USD 290.23M 2.32M 2025-09
Sartorius EUR 827.9M 30.5M 2025-09
Sino Biopharmaceutical CNY 1.84B 156.17M 2024-06
Tilray USD 282.79M 11.9M 2025-06
Zealand Pharma A/S 10.7M 9.9M 2024-12